Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using open-label placebos to reduce acute pain in healthy adults

Official title: Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults

Run by University Hospital, Basel, Switzerland · NCT05819476 · Data updated 2026-11-12

This study tests whether open-label placebos can help healthy adults feel less pain from simulated wounds caused by electrical stimulation.

More Acute Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment141 (estimated)
SponsorUniversity Hospital, Basel, Switzerland
Academic / other
Locations1 site (Basel)
StatusRecruiting
StartedMarch 23, 2023
Main results expectedJune 2025
Study endsJune 2025
Registry record updatedJanuary 24, 2025
Trial IDNCT05819476 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults aged 18 to 65 with a BMI between 18 and 25 who can understand the study and provide informed consent.

Probably not a fit

Patients with chronic pain, neuropathy, or those taking medications that interfere with pain sensation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of open-label placebo (OLP) on acute pain using an experimental model that simulates wound pain through electrical stimulation. Participants will undergo a randomized crossover design where they will receive OLP injections and their pain responses will be measured. The study aims to evaluate the duration and efficacy of OLP analgesia, comparing different administration methods. The research seeks to explore the potential of OLP as a non-deceptive treatment option for managing acute pain.

Why it matters

Potential benefit: If successful, this approach could provide a novel, non-pharmacological method for managing acute pain without the side effects associated with traditional analgesics.

How similar studies have gone: While the use of open-label placebos is a relatively novel approach, previous studies have shown promising results in various conditions, indicating potential for success in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Healthy volunteers (ASA Class I or II), aged 18 to 65 years
* BMI between 18 and 25kg/m2
* Able to understand the study and the NRS
* Able to give informed consent

Exclusion Criteria:

* Participation in a previous open-label placebo study; for Part 2, this includes Part 1 of this study
* Regular intake of medications or drugs potentially interfering with pain sensation (analgesics, opioids, antihistamines, calcium and potassium channel blockers, serotonin/ noradrenaline reuptake inhibitors, corticosteroids)
* Neuropathy
* Chronic pain
* Neuromuscular disease
* Dermatological disease (i.e. Atopic Dermatitis)
* Psychiatric disease
* Pregnancy / Lactation

Where it's running

  • University Hospital of Basel (USB); Department of Anaesthesiology
    Basel, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Tobias Schneider, MD — Department of Anaesthesiology, University Hospital of Basel (USB)
  • Study coordinator: Tobias Schneider, MD
  • Email: tobias.schneider@usb.ch
  • Phone: +41 61 328 65 43

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.